NO20034245D0 - Aromataseinhibering for å öke kunstig befruktning - Google Patents

Aromataseinhibering for å öke kunstig befruktning

Info

Publication number: NO20034245D0
Authority: NO; Norway
Prior art keywords: aromatase inhibition; artificial fertilization; increase artificial; increase; fertilization
Prior art date: 2001-04-17

Application number

NO20034245A

Other languages

English (en)

Other versions

NO20034245L (no

Inventor

Robert F Casper

Mohamed F M Mitwally

Original Assignee

Ares Trading Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-17

Filing date

2003-09-23

Publication date

2003-09-23

2003-09-23 Application filed by Ares Trading Sa filed Critical Ares Trading Sa

2003-09-23 Publication of NO20034245D0 publication Critical patent/NO20034245D0/no

2003-12-15 Publication of NO20034245L publication Critical patent/NO20034245L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20034245A 2001-04-17 2003-09-23 Aromataseinhibering for å öke assistert forplantning NO20034245L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28417801P	2001-04-17	2001-04-17
PCT/CA2002/000522 WO2002083240A1 (en)	2001-04-17	2002-04-17	Aromatase inhibition to enhance assisted reproduction

Publications (2)

Publication Number	Publication Date
NO20034245D0 true NO20034245D0 (no)	2003-09-23
NO20034245L NO20034245L (no)	2003-12-15

Family

ID=23089175

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034245A NO20034245L (no)	2001-04-17	2003-09-23	Aromataseinhibering for å öke assistert forplantning

Country Status (33)

Country	Link
US (1)	US7846957B2 (no)
EP (1)	EP1381431B1 (no)
JP (1)	JP2004526764A (no)
KR (1)	KR20040012751A (no)
CN (1)	CN100377710C (no)
AR (1)	AR034310A1 (no)
AT (1)	ATE363906T1 (no)
AU (1)	AU2002249041B2 (no)
BG (1)	BG108316A (no)
BR (1)	BR0208968A (no)
CA (1)	CA2444932A1 (no)
CY (1)	CY1108021T1 (no)
CZ (1)	CZ299735B6 (no)
DE (1)	DE60220516T2 (no)
DK (1)	DK1381431T3 (no)
EA (1)	EA010354B1 (no)
EE (1)	EE200300512A (no)
ES (1)	ES2283541T3 (no)
HK (1)	HK1067987A1 (no)
HR (1)	HRP20030838A2 (no)
HU (1)	HUP0303795A2 (no)
IL (2)	IL158395A0 (no)
MX (1)	MXPA03009446A (no)
NO (1)	NO20034245L (no)
NZ (1)	NZ528501A (no)
PL (1)	PL366554A1 (no)
PT (1)	PT1381431E (no)
SI (1)	SI1381431T1 (no)
SK (1)	SK14252003A3 (no)
UA (1)	UA79591C2 (no)
WO (1)	WO2002083240A1 (no)
YU (1)	YU81303A (no)
ZA (1)	ZA200307514B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL373219A1 (en) *	2002-07-02	2005-08-22	Pharmacia & Upjohn Company Llc	Infertility treatment with exemestane
NZ603548A (en) *	2010-05-20	2014-06-27	Univ Saskatchewan	Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal
WO2012127501A2 (en) *	2011-03-11	2012-09-27	Sanzyme Limited	Composition for improving endometrial thickness during ovarian stimulation
DK2753313T3 (en)	2011-09-08	2017-02-13	Mereo Biopharma 2 Ltd	PHARMACEUTICAL COMPOSITIONS INCLUDING AN AROMATASE INHIBITOR
WO2014169395A1 (en)	2013-04-19	2014-10-23	University Of Saskatchewan	Aromatase inhibitor-releasing intravaginal device
CN107648594A (zh) *	2017-11-08	2018-02-02	广州市桐晖药业有限公司	枸橼酸氯米芬胶囊及其制备方法
CN118286143A (zh) *	2024-03-20	2024-07-05	郑州大学第三附属医院(河南省妇幼保健院)	注射用尿促卵泡素联合来曲唑在制备不孕症的试剂盒中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4289762A (en) *	1980-06-27	1981-09-15	Merrell Dow Pharmaceuticals Inc.	10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4728645A (en) *	1982-12-21	1988-03-01	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4845227A (en) *	1984-06-18	1989-07-04	Eli Lilly And Company	Aromatase inhibitors from azoles
US4978672A (en) *	1986-03-07	1990-12-18	Ciba-Geigy Corporation	Alpha-heterocyclc substituted tolunitriles
DE4330237C2 (de) *	1993-09-02	1995-11-30	Schering Ag	1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0907351B2 (de)	1996-03-29	2012-04-18	Keyvest GmbH	Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
EP0906115A1 (en)	1996-04-30	1999-04-07	Takeda Chemical Industries, Ltd.	COMBINED USE OF GnRH AGONIST AND ANTAGONIST
DE19622457A1 (de)	1996-05-24	1997-11-27	Schering Ag	7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
DE69831241T2 (de) *	1997-06-20	2006-03-23	Akzo Nobel N.V.	Gonadotropin freisetzendes Hormon Antagonist
US6953774B2 (en) *	2000-08-11	2005-10-11	Applied Research Systems Ars Holding N.V.	Methods of inducing ovulation

2002
- 2002-04-17 CA CA002444932A patent/CA2444932A1/en not_active Abandoned
- 2002-04-17 AU AU2002249041A patent/AU2002249041B2/en not_active Ceased
- 2002-04-17 PL PL02366554A patent/PL366554A1/xx not_active Application Discontinuation
- 2002-04-17 CZ CZ20033108A patent/CZ299735B6/cs not_active IP Right Cessation
- 2002-04-17 JP JP2002581040A patent/JP2004526764A/ja active Pending
- 2002-04-17 SK SK1425-2003A patent/SK14252003A3/sk unknown
- 2002-04-17 EE EEP200300512A patent/EE200300512A/xx unknown
- 2002-04-17 IL IL15839502A patent/IL158395A0/xx unknown
- 2002-04-17 WO PCT/CA2002/000522 patent/WO2002083240A1/en active IP Right Grant
- 2002-04-17 UA UA20031110267A patent/UA79591C2/uk unknown
- 2002-04-17 AR ARP020101398A patent/AR034310A1/es unknown
- 2002-04-17 DK DK02717917T patent/DK1381431T3/da active
- 2002-04-17 KR KR10-2003-7013483A patent/KR20040012751A/ko not_active Application Discontinuation
- 2002-04-17 AT AT02717917T patent/ATE363906T1/de active
- 2002-04-17 US US10/475,172 patent/US7846957B2/en not_active Expired - Fee Related
- 2002-04-17 MX MXPA03009446A patent/MXPA03009446A/es not_active Application Discontinuation
- 2002-04-17 PT PT02717917T patent/PT1381431E/pt unknown
- 2002-04-17 EA EA200301129A patent/EA010354B1/ru not_active IP Right Cessation
- 2002-04-17 ES ES02717917T patent/ES2283541T3/es not_active Expired - Lifetime
- 2002-04-17 DE DE60220516T patent/DE60220516T2/de not_active Expired - Lifetime
- 2002-04-17 HU HU0303795A patent/HUP0303795A2/hu unknown
- 2002-04-17 YU YU81303A patent/YU81303A/sh unknown
- 2002-04-17 BR BR0208968-8A patent/BR0208968A/pt not_active IP Right Cessation
- 2002-04-17 SI SI200230565T patent/SI1381431T1/sl unknown
- 2002-04-17 NZ NZ528501A patent/NZ528501A/en not_active IP Right Cessation
- 2002-04-17 CN CNB028123190A patent/CN100377710C/zh not_active Expired - Fee Related
- 2002-04-17 EP EP02717917A patent/EP1381431B1/en not_active Expired - Lifetime
2003
- 2003-09-23 NO NO20034245A patent/NO20034245L/no not_active Application Discontinuation
- 2003-09-26 ZA ZA200307514A patent/ZA200307514B/en unknown
- 2003-10-14 IL IL158395A patent/IL158395A/en not_active IP Right Cessation
- 2003-10-15 HR HR20030838A patent/HRP20030838A2/xx not_active Application Discontinuation
- 2003-11-05 BG BG108316A patent/BG108316A/bg unknown
2005
- 2005-02-15 HK HK05101178A patent/HK1067987A1/xx not_active IP Right Cessation
2007
- 2007-07-19 CY CY20071100965T patent/CY1108021T1/el unknown

Also Published As

Publication number	Publication date
HRP20030838A2 (en)	2005-08-31
SK14252003A3 (sk)	2004-03-02
AR034310A1 (es)	2004-02-18
BR0208968A (pt)	2004-04-27
US20040204393A1 (en)	2004-10-14
JP2004526764A (ja)	2004-09-02
HK1067987A1 (en)	2005-04-22
WO2002083240A9 (en)	2004-05-06
CZ20033108A3 (en)	2004-06-16
CN100377710C (zh)	2008-04-02
CA2444932A1 (en)	2002-10-24
EA010354B1 (ru)	2008-08-29
KR20040012751A (ko)	2004-02-11
EE200300512A (et)	2004-02-16
US7846957B2 (en)	2010-12-07
WO2002083240A1 (en)	2002-10-24
NZ528501A (en)	2008-04-30
NO20034245L (no)	2003-12-15
IL158395A0 (en)	2004-05-12
AU2002249041B2 (en)	2007-07-12
DE60220516D1 (de)	2007-07-19
CZ299735B6 (cs)	2008-11-05
ATE363906T1 (de)	2007-06-15
DK1381431T3 (da)	2007-10-08
SI1381431T1 (sl)	2007-08-31
IL158395A (en)	2009-06-15
ZA200307514B (en)	2004-09-27
HUP0303795A2 (hu)	2004-03-29
PT1381431E (pt)	2007-07-03
MXPA03009446A (es)	2004-05-24
PL366554A1 (en)	2005-02-07
CY1108021T1 (el)	2013-09-04
UA79591C2 (en)	2007-07-10
EA200301129A1 (ru)	2004-04-29
ES2283541T3 (es)	2007-11-01
YU81303A (sh)	2006-05-25
EP1381431B1 (en)	2007-06-06
BG108316A (bg)	2004-12-30
CN1549734A (zh)	2004-11-24
DE60220516T2 (de)	2007-10-11
EP1381431A1 (en)	2004-01-21

Publication	Publication Date	Title
EE200300088A (et)	2005-02-15	Imidasolo-5-üül-2-anilino-pürimidiinid raku proliferatsiooni inhibitsiooni agensitena
EP1667522A4 (en)	2011-04-27	MODIFIED OLIGONUCLEOTIDES FOR INHIBITING TELOMERASE
DK1294644T3 (da)	2010-11-08	Vandbehandlingssammensætninger
IS7657A (is)	2005-01-20	thíófen efnasambönd
DE60319353D1 (de)	2008-04-10	Verzweigte gefässstütze
DE60000944D1 (de)	2003-01-23	Bohrlochzementzusammensetzungen
FR2842417B1 (fr)	2005-01-21	Composition cosmetique
FR2842416B1 (fr)	2004-12-17	Composition cosmetique
EP1561476A4 (en)	2006-09-06	DESODRATING COMPOSITION
DE60211740D1 (de)	2006-06-29	Zusammensetzung zur saatgutbehandlung
DE60025624D1 (de)	2006-04-06	Farbstabile polyarylat enthaltende zusammensetzungen
FR2871145B1 (fr)	2006-08-18	Distributeur d'applicateurs
DE60320902D1 (de)	2008-06-26	Zusammensetzungen mit ausgelöster Freisetzung
DE60316954D1 (de)	2007-11-29	Shampoozusammensetzungen
NO20052193D0 (no)	2005-05-04	Korrosjonshemmende sammensetning
SE0500163L (sv)	2005-01-24	Sammansättning
NO20034245D0 (no)	2003-09-23	Aromataseinhibering for å öke kunstig befruktning
DE60103292D1 (de)	2004-06-17	Fungizide zusammensetzungen
FI20020313A (fi)	2003-08-16	Uudet tärkkelyskoostumukset
DE60009260D1 (de)	2004-04-29	Thiopyranderivate as mmp-inhibitoren
DE60216645D1 (de)	2007-01-18	Antiulcus pflanzenzusammensetzung(en)
NO20024880D0 (no)	2002-10-09	Sammensetning inneholdende fosfat
DE60307471D1 (de)	2006-09-21	Hemmung
DE60001566D1 (de)	2003-04-10	Fungizide zusammensetzungen
GB2392384B (en)	2004-08-11	Compositions for topical application

Legal Events

Date	Code	Title	Description
2013-12-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application